The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration. (8th August 2022)

• Record Type: Journal Article
• Authors: Quicke, Kendra M.; Baxter, Bridget A.; Stromberg, Sophia; Gallichotte, Emily N.; Fitzmeyer, Emily; Young, Michael C.; Pabilonia, Kristy L.; Ehrhart, Nicole; Dunn, Julie; Ebel, Gregory D.; Ryan, Elizabeth P.
• Other Names: Brown Jay C. Academic Editor.
• Is Part Of: Advances in virology. Volume 2022(2022)
• Publication Date: 2022-08-08
• Subjects: Virology -- Periodicals; 616.9101
• DOI: 10.1155/2022/1378482
• Languages: English
• ISSNs: 1687-8639

Abstract

Abstract : SARS-CoV-2 emerged in 2019 and rapidly surged into a global pandemic. The rates of concurrent infection with other respiratory pathogens and the effects of possible coinfections on the severity of COVID-19 cases and the length of viral infection are not well defined. In this retrospective study, nasopharyngeal swab samples collected in Colorado between March 2020 and May 2021 from SARS-CoV-2 PCR-positive individuals were tested for a panel of 21 additional respiratory pathogens, including 17 viral and 4 bacterial pathogens. We detected significant positive correlations between levels of SARS-CoV-2 RNA and infectious virus titers for both cohorts, as well as a positive correlation between viral RNA levels and disease severity scores for one cohort. We hypothesized that severe COVID-19 cases and longer SARS-CoV-2 infections may be associated with concurrent respiratory infections. Only one individual exhibited evidence of a concurrent infection- SARS -CoV-2 and human rhinovirus/enterovirus- leading us to conclude that viral respiratory coinfections were uncommon during this time and thus not responsible for the variations in disease severity and infection duration observed in the two cohorts examined. Mask wearing and other public health measures were imposed in Colorado during the time of collection and likely contributed to low rates of coinfection.